Last year, the National Institutes of Health (NIH) paid the University of California more than a million dollars to study whether specialized cellular immunotherapies can extend the lives of cancer patients who are otherwise out of options. To date, cellular immunotherapy has revolutionized cancer treatment. Naturally, taxpayers across the country would think allocating a million dollars to study a potential cure for cancer is well within reason.
At least that is what they think.
What taxpayers might not know is that nearly 40 percent of this research funding won’t be used to find a cure for cancer at all. Instead, it will fund the
House Freedom Caucus Chair: Trump Protecting Critical Medical Research | Opinion
